Evidence-Based Core Clinical Pharmacy Services in United States Hospitals in 2020: Services and Staffing

Pharmacotherapy

Volumn 24, Issue 4, 2004, Pages 427-440

  Bond, C A ^a   Raehl, Cynthia L ^a   Patry, Roland ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Core clinical pharmacy services; Future pharmacy needs; Outcome measure; Pharmacist staffing

Indexed keywords

CLINICAL PHARMACY; DRUG COST; EVIDENCE BASED MEDICINE; FUTUROLOGY; HEALTH SERVICE; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HOSPITALIZATION; MANPOWER; OUTCOMES RESEARCH; PATIENT CARE; PRESCRIPTION; REIMBURSEMENT; REVIEW; TRAINING;

COSTS AND COST ANALYSIS; EVIDENCE-BASED MEDICINE; MODELS, ORGANIZATIONAL; OUTCOME ASSESSMENT (HEALTH CARE); PERSONNEL STAFFING AND SCHEDULING; PHARMACY SERVICE, HOSPITAL;

EID: 1842427895     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.5.427.33358     Document Type: Review

References (61)

1. American College of Clinical Pharmacy. A vision of pharmacy's future roles, responsibilities, and manpower needs in the United States. Pharmacotherapy 2000;20(8):991-1022.
2. Bond CA, Raehl CL, Patry R. The feasibility of implementing an evidence-based core set of clinical pharmacy services in 2020: manpower, marketplace factors, and pharmacy leadership. Pharmacotherapy 2004;24(4):441-52.
3. Joint Commission on Accreditation of Healthcare Organizations. JCAHO comprehensive accreditation manual for hospitals: the official handbook. Oakbrook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations, 2001.
4. Joint Commission on Accreditation of Healthcare Organizations. 2004 pre-publication guidelines. Available from http://www.jcaho.org/accredited+organizations/2004+stand. Accessed June 17, 2003.
5. Study Commission on Pharmacy. Pharmacists for the future. Ann Arbor, MI: Health Administration Press, 1975.
6. American Society of Hospital Pharmacists. Directions for clinical practice in pharmacy: proceedings of an invitational conference conducted by the ASHP Research and Education Foundation and the American Society of Hospital Pharmacists, Hilton Head Island, South Carolina, February 10-13, 1985. Am J Hosp Pharm 985;42:1287-342.
7. Bezold C, Halperin JA, Binkley HL, et al, eds. Pharmacy in the 21st century: planning for an uncertain future. Washington, DC: Institute for Alternative Futures and Project HOPE, 1985.
8. Cocolas GH. Conference on pharmacy in the 21st century, October 11-14, 1989, Williamsburg, Virginia. Am J Pharm Educ 1989;winter suppl:S1-63.
9. American Society of Hospital Pharmacists. Implementing pharmaceutical care: proceedings of an invitational conference conducted by the American Society of Hospital Pharmacists and the ASHP Research and Education Foundation, San Antonio, Texas, March 12-15, 1993. Am J Hosp Pharm 1993;50:1585-656.
10. Zilz DA. The changing healthcare system: implications for pharmaceutical care: proceedings from the third strategic planning conference for pharmacy practice, pharmacy in the 21st century. Am Pharm 1995;NS 35(7 suppl):S6-12.
11. Hatoum HT, Catizone C, Hutchinson RA, et al. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986;20:33-48.
12. Black BL. Resource book on progressive pharmaceutical services. Bethesda, MD: American Society of Hospital Pharmacists, 1986.
13. Comptroller General of the United States. Study of health facilities construction costs. Washington, DC: U.S. Government Printing Office, 1972:68-72, 363-79.
14. Barker KN, Pearson RE. Medication distribution systems. In: Brown TR, Smith MC, eds. Handbook of institutional pharmacy practice. Baltimore, MD: Williams & Wilkins, 1986:325-51.
15. Elenbaas RM, Payne VW, Bauman JL. Influence of clinical pharmacists' consultations on the use of drug blood level test. Am J Hosp Pharm 1980;37:61-4.
16. Bollish SJ, Kelly WN, Miller DE, et al. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital. Am J Hosp Pharm 1981;38:73-6.
17. Abramowitz PA, Nold EC, Hatfield SM. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs. Am J Hosp Pharm 1982;39:1176-80.
18. Mutchie KD, Smith KA, MacKay MW, et al. Pharmacist monitoring of parenteral nutrition: clinical and cost effectiveness. Am J Hosp Pharm 1979;36:785-7.
19. Covinsky JO, Hamburger SC, Kelly KL, et al. Impact of docent clinical pharmacists on treatment of streptococcal pneumonia. Drug Intell Clin Pharm 1982;16:587-91.
20. Bond CA, Salinger RJ. Fluphenazine outpatient clinics: a pharmacist's role. J Clin Psychiatry 1979;40:501-3.
21. Herfindal ET, Bernstein LR, Kishi DT. Effect of clinical pharmacy services on prescribing on an orthopedic unit. Am J Hosp Pharm 1983;40:1945-51.
22. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63.
23. Knapp DE, Knapp DA, Speedie MK, et al. Relationship of inappropriate drug prescribing to increased length of hospital stay. Am J Hosp Pharm 1979;36:1334-7.
24. Knapp DE, Speedie MK, Yaeger DM, et al. Drug prescribing and its relationship to length of hospital stay. Inquiry 1980;17:254-9.
25. McKenney JM, Wasserman AH. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions. Am J Hosp Pharm 1979;36:1691-7.
26. Clapham CE, Hepler CE, Reinders TP, et al. Economic consequences of two drug-use control systems in a teaching hospital. Am J Hosp Pharm 1988;45:2329-40.
27. Bjornson DC, Hiner WO, Potyk RP, et al. Effect of a pharmacist on healthcare outcomes in hospitalized patients. Am J Hosp Pharm 1993;50:1875-84.
28. Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy 1996;16(4):708-14.
29. Monson RA, Bond CA, Schuna A. Role of the clinical pharmacist in improving outpatient drug therapy. Arch Intern Med 1981;141:1441-4.
30. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control: a four year ambulatory care model. Arch Intern Med 1984;144:1159-62.
31. Tang I, Vrahnos D, Hatoum H, et al. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993:15;15459-64.
32. Brown WJ. Pharmacist participation on a multidisciplinary rehabilitation team. Am J Hosp Pharm 1994;51:91-2.
33. Garber AM, Fuchs VR, Silverman JF. Case mix, costs, and outcomes: between faculty and community services in a university hospital. N Engl J Med 1984;310:1231-7.
34. Pauly MV, Wilson P. Hospital output forecasts and the cost of empty hospital beds. Health Serv Res 1986;21:413-28.
35. Rich EC, Gifford G, Luxenberg M, et al. The relationship of hospital staff experiences to the cost and quality of inpatient care. JAMA 1990;263:953-7.
36. Watts CA, Klastorin TD. The impact of case mix on hospital costs: a comparative analysis. Inquiry 1990;17:357-67.
37. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluation of clinical pharmacy services: 1988-1995. Pharmacotherapy 1996;16(6):1188-208.
38. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure team. Arch Intern Med 1999;159:1939-45.
39. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70.
40. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001:285:2114-20.
41. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23(1):113-32.
42. Bond CA, Raehl CL, Pitterle ME, Franke T. Healthcare professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999;19(2):130-8.
43. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy 1999;19(5):556-64.
44. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals. Pharmacotherapy 1999;19(12)1354-62.
45. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 2000;20(6);609-21.
46. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy 2001;21(2):129-41.
47. Bond CA, Raehl CI, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 2002;22(2):134-47.
48. Raehl CL, Bond CA, Pitterle ME. Pharmaceutical services in U.S. hospitals in 1989. Am J Hosp Pharm 1992:49:323-46.
49. Bond CA, Raehl CL, Pitterle ME. 1992 National clinical pharmacy services study. Pharmacotherapy 1994:14(3): 282-304.
50. Raehl CL, Bond CA, Pitterle ME. 1995 National clinical pharmacy services survey. Pharmacotherapy 1998;18(2): 282-304.
51. Raehl CL, Bond CA. 1998 National clinical pharmacy services study. Pharmacotherapy 2000;20(4):436-60.
52. American Health-System Association. American Health-System Association abridged guide to the health care field (on diskettes). Chicago, IL: American Health-System Association, 2000.
53. Raehl CL, Bond CA, Pitterle ME. Hospital pharmacy services in the Great Lakes region. Am J Hosp Pharm 1992;47:1283-303.
54. Bond CA, Raehl CL, Franke T. Medication errors in United States hospitals. Pharmacotherapy 2001;21(9):1023-36.
55. Pitterle ME, Bond CA, Raehl CL, Franke T. Hospital and pharmacy characteristics associated with mortality rates in United States hospitals. Pharmacotherapy 1994;14(5):620-30.
56. American Health-System Association. American Health-System abridged guide to the health care field (on diskettes). Chicago, IL: American Health-System Association, 1998.
57. American Health-System Association. American Health-System Association abridged guide to the health care field (on diskettes). Chicago, IL: American Health-System Association, 1995.
58. United States Census Bureau. Annual projections of total resident population. Available from http://www.census.gov/ population/projections/nation/summary/np-t1.pdf. Accessed June 10, 2003.
59. Bond CA, Raehl CL, Franke T. Staffing and the cost of clinical pharmacy services in United States hospitals. Pharmacotherapy 1999;19(6):767-81.
60. Hepler D, Strand L. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
61. National Association of Boards of Pharmacy. 2002-2003 Survey of pharmacy law. Park Ridge, IL: National Association of Boards of Pharmacy, 2003:64-5.